223 related articles for article (PubMed ID: 25848723)
1. Lectin RCA-I specifically binds to metastasis-associated cell surface glycans in triple-negative breast cancer.
Zhou SM; Cheng L; Guo SJ; Wang Y; Czajkowsky DM; Gao H; Hu XF; Tao SC
Breast Cancer Res; 2015 Mar; 17(1):36. PubMed ID: 25848723
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy enriches for an invasive triple-negative breast tumor cell subpopulation expressing a precursor form of N-cadherin on the cell surface.
Nelson ER; Li S; Kennedy M; Payne S; Kilibarda K; Groth J; Bowie M; Parilla-Castellar E; de Ridder G; Marcom PK; Lyes M; Peterson BL; Cook M; Pizzo SV; McDonnell DP; Bachelder RE
Oncotarget; 2016 Dec; 7(51):84030-84042. PubMed ID: 27768598
[TBL] [Abstract][Full Text] [Related]
3. Glycans unique to the relapse-prone subset within triple-negative breast cancer as revealed by lectin array-based analysis of surgical specimens.
Sakata-Matsuzawa M; Denda-Nagai K; Fujihira H; Noji M; Ishii-Schrade KB; Matsuda A; Kuno A; Okazaki M; Nakai K; Horimoto Y; Saito M; Irimura T
PLoS One; 2021; 16(5):e0250747. PubMed ID: 33974630
[TBL] [Abstract][Full Text] [Related]
4. E1A-mediated inhibition of HSPA5 suppresses cell migration and invasion in triple-negative breast cancer.
Chen HA; Chang YW; Tseng CF; Chiu CF; Hong CC; Wang W; Wang MY; Hsiao M; Ma JT; Chen CH; Jiang SS; Wu CH; Hung MC; Huang MT; Su JL
Ann Surg Oncol; 2015 Mar; 22(3):889-98. PubMed ID: 25212833
[TBL] [Abstract][Full Text] [Related]
5. Brain-derived neurotrophic factor (BDNF) -TrKB signaling modulates cancer-endothelial cells interaction and affects the outcomes of triple negative breast cancer.
Tsai YF; Tseng LM; Hsu CY; Yang MH; Chiu JH; Shyr YM
PLoS One; 2017; 12(6):e0178173. PubMed ID: 28604807
[TBL] [Abstract][Full Text] [Related]
6. SCEL regulates switches between pro-survival and apoptosis of the TNF-α/TNFR1/NF-κB/c-FLIP axis to control lung colonization of triple negative breast cancer.
Chan SH; Kuo WH; Wang LH
J Biomed Sci; 2023 Nov; 30(1):93. PubMed ID: 38037106
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin.
Wu YM; Chen ZJ; Liu H; Wei WD; Lu LL; Yang XL; Liang WT; Liu T; Liu HL; Du J; Wang HS
Oncotarget; 2015 Sep; 6(28):25588-601. PubMed ID: 26160845
[TBL] [Abstract][Full Text] [Related]
8. N-Linked glycosylation profiles of therapeutic induced senescent (TIS) triple negative breast cancer cells (TNBC) and their extracellular vesicle (EV) progeny.
Kavanagh EL; Halasz M; Dowling P; Withers J; Lindsay S; Higgins MJ; Irwin JA; Rudd PM; Saldova R; McCann A
Mol Omics; 2021 Feb; 17(1):72-85. PubMed ID: 33325943
[TBL] [Abstract][Full Text] [Related]
9. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
[TBL] [Abstract][Full Text] [Related]
10. CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation.
Wright HJ; Hou J; Xu B; Cortez M; Potma EO; Tromberg BJ; Razorenova OV
Proc Natl Acad Sci U S A; 2017 Aug; 114(32):E6556-E6565. PubMed ID: 28739932
[TBL] [Abstract][Full Text] [Related]
11. Significantly increased PELP1 protein expression in primary and metastatic triple-negative breast carcinoma: comparison with GATA3 expression and PELP1's potential role in triple-negative breast carcinoma.
Dang DN; Raj G; Sarode V; Molberg KH; Vadlamudi RK; Peng Y
Hum Pathol; 2015 Dec; 46(12):1829-35. PubMed ID: 26428280
[TBL] [Abstract][Full Text] [Related]
12. Identification and analysis of altered alpha1,6-fucosylated glycoproteins associated with hepatocellular carcinoma metastasis.
Dai Z; Liu YK; Cui JF; Shen HL; Chen J; Sun RX; Zhang Y; Zhou XW; Yang PY; Tang ZY
Proteomics; 2006 Nov; 6(21):5857-67. PubMed ID: 17068759
[TBL] [Abstract][Full Text] [Related]
13. Identification of cell surface glycoprotein markers for glioblastoma-derived stem-like cells using a lectin microarray and LC-MS/MS approach.
He J; Liu Y; Xie X; Zhu T; Soules M; DiMeco F; Vescovi AL; Fan X; Lubman DM
J Proteome Res; 2010 May; 9(5):2565-72. PubMed ID: 20235609
[TBL] [Abstract][Full Text] [Related]
14. Clinical implication of leucine zipper/EF hand-containing transmembrane-1 overexpression in the prognosis of triple-negative breast cancer.
Wang CA; Liu Q; Chen Y; Liu S; Xu J; Cui X; Zhang Y; Piao L
Exp Mol Pathol; 2015 Apr; 98(2):254-9. PubMed ID: 25617527
[TBL] [Abstract][Full Text] [Related]
15. Role of cell surface oligosaccharides of mouse mammary tumor cell lines in cancer metastasis.
Zhao Y; Li J; Wang J; Xing Y; Geng M
Indian J Biochem Biophys; 2007 Jun; 44(3):145-51. PubMed ID: 17650582
[TBL] [Abstract][Full Text] [Related]
16. Rampant centrosome amplification underlies more aggressive disease course of triple negative breast cancers.
Pannu V; Mittal K; Cantuaria G; Reid MD; Li X; Donthamsetty S; McBride M; Klimov S; Osan R; Gupta MV; Rida PC; Aneja R
Oncotarget; 2015 Apr; 6(12):10487-97. PubMed ID: 25868856
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer.
Granados-Principal S; Liu Y; Guevara ML; Blanco E; Choi DS; Qian W; Patel T; Rodriguez AA; Cusimano J; Weiss HL; Zhao H; Landis MD; Dave B; Gross SS; Chang JC
Breast Cancer Res; 2015 Feb; 17(1):25. PubMed ID: 25849745
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of α-L-fucosidase 1 expression confers inferior survival for triple-negative breast cancer patients by modulating the glycosylation status of the tumor cell surface.
Cheng TC; Tu SH; Chen LC; Chen MY; Chen WY; Lin YK; Ho CT; Lin SY; Wu CH; Ho YS
Oncotarget; 2015 Aug; 6(25):21283-300. PubMed ID: 26204487
[TBL] [Abstract][Full Text] [Related]
19. Depletion of SENP1 suppresses the proliferation and invasion of triple-negative breast cancer cells.
Wang Z; Jin J; Zhang J; Wang L; Cao J
Oncol Rep; 2016 Oct; 36(4):2071-8. PubMed ID: 27573572
[TBL] [Abstract][Full Text] [Related]
20. Chrysin inhibits metastatic potential of human triple-negative breast cancer cells by modulating matrix metalloproteinase-10, epithelial to mesenchymal transition, and PI3K/Akt signaling pathway.
Yang B; Huang J; Xiang T; Yin X; Luo X; Huang J; Luo F; Li H; Li H; Ren G
J Appl Toxicol; 2014 Jan; 34(1):105-12. PubMed ID: 24122885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
